Found 5249 matching trials
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
PHASE2Eighty to 90% of SCCHN (squamous cell carcinoma of head and neck) patients ...
Location
Chang Gung Memorial Hospital
4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer
PHASE3RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Location
Banner Thunderbird Medical Center
Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma
PHASE2To evaluate whether the 2-year local failure-free survival (LRFFS) in Cohor...
Location
Fudan Universtiy Shanghai Cancer Center
Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)
PHASE2This is an open, multi-cohort, multi-center, exploratory and phase II clini...
Location
Jiangsu Cancer Hospital
Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors
PHASE1PI3K signaling is a hallmark of many cancers. Subsets of cancers become dep...
Location
Ospedale San Raffaele
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
PHASE1Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
PHASE4Research purpose:
Degree of continuous intravenous pumping Endostar (human...
Location
Jiangsu Taizhou People's Hospital
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
PHASE2To determine the rate of pathologic complete responses (pCR) at the time of...
Location
Western Regional Medical Center
A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer
PHASE2This phase II trial on the assumption that abraxane and cisplatin combinati...
Location
Fudan University Cancer Hospital
Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.
PHASE2The primary purpose of this trial is to evaluate the efficacy and tolerabil...
Location
St George Hospital